You will receive alerts when there are new announcements on Akari Therapeutics
Only registered members can use this feature.
We are developing life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.